Drug Shortage Report for CLOLAR
Report ID | 151265 |
Drug Identification Number | 02330407 |
Brand name | CLOLAR |
Common or Proper name | Clolar |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | CLOFARABINE |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1 |
ATC code | L01BB |
ATC description | ANTIMETABOLITES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2021-12-14 |
Estimated end date | 2022-04-22 |
Actual end date | 2022-04-22 |
Shortage status | Resolved |
Updated date | 2022-04-25 |
Company comments | The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-12-16 | English | Compare |
v2 | 2021-12-16 | French | Compare |
v3 | 2022-01-19 | English | Compare |
v4 | 2022-01-19 | French | Compare |
v5 | 2022-04-25 | English | Compare |
v6 | 2022-04-25 | French | Compare |
Showing 1 to 6 of 6